HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B E Sobel Selected Research

Obesity

9/2001Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
6/2001Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice.
4/2000Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B E Sobel Research Topics

Disease

5Insulin Resistance
03/2004 - 04/2000
5Atherosclerosis
12/2002 - 04/2000
4Acute Coronary Syndrome
03/2004 - 02/2000
4Type 2 Diabetes Mellitus (MODY)
09/2001 - 04/2000
3Myocardial Infarction
01/2009 - 03/2000
3Rupture
03/2004 - 03/2000
3Atherosclerotic Plaque (Atheroma)
03/2004 - 03/2000
3Obesity
09/2001 - 04/2000
2Infarction (Infarctions)
12/2001 - 07/2000
2Unstable Angina
04/2000 - 03/2000
1Diabetes Mellitus
01/2004
1Hepatocellular Carcinoma (Hepatoma)
12/2002
1Stable Angina
10/2001
1Coronary Disease (Coronary Heart Disease)
06/2001
1Fibrosis (Cirrhosis)
06/2001
1Insulinoma
06/2001
1Cardiovascular Diseases (Cardiovascular Disease)
02/2001
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
04/2000
1Hyperinsulinism (Hyperinsulinemia)
04/2000
1Down Syndrome (Down's Syndrome)
03/2000
1Vascular Diseases (Vascular Disease)
03/2000

Drug/Important Bio-Agent (IBA)

7Plasminogen InactivatorsIBA
12/2002 - 03/2000
5Plasminogen Activator Inhibitor 1IBA
12/2002 - 04/2000
4Insulin (Novolin)FDA Link
03/2004 - 04/2000
3Troglitazone (Rezulin)FDA Link
03/2004 - 04/2000
2Tissue Plasminogen Activator (Alteplase)FDA Link
12/2001 - 04/2000
2Glucose (Dextrose)FDA LinkGeneric
05/2001 - 04/2000
1Apolipoproteins E (ApoE)IBA
03/2004
1Triglycerides (Triacylglycerol)IBA
03/2004
1Rosiglitazone (Avandia)FDA Link
03/2004
1ApolipoproteinsIBA
03/2004
1HDL CholesterolIBA
03/2004
1LipidsIBA
03/2004
1Glycoproteins (Glycoprotein)IBA
01/2004
1Platelet Membrane Glycoprotein IIbIBA
01/2004
1Fatty Acids (Saturated Fatty Acids)IBA
12/2002
1Bovine Serum AlbuminIBA
12/2002
1adhesion receptorIBA
12/2001
1Monoclonal AntibodiesIBA
12/2001
1Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2001
1CD18 AntigensIBA
12/2001
1ThrombinFDA Link
10/2001
1ProinsulinIBA
09/2001
1Thromboplastin (Tissue Factor)IBA
06/2001
1Messenger RNA (mRNA)IBA
06/2001
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2001
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2001
1Abciximab (ReoPro)FDA Link
02/2001
1Plasminogen Activators (Plasminogen Activator)IBA
07/2000
1Creatine Kinase (Creatine Phosphokinase)IBA
04/2000
1TroponinIBA
04/2000
1AntigensIBA
04/2000
1IsoenzymesIBA
04/2000
1Phenobarbital (Luminal)FDA Link
03/2000
1orbofibanIBA
02/2000

Therapy/Procedure

2Therapeutics
12/2002 - 10/2001
1Thrombolytic Therapy
01/2009
1Catheters
10/2001
1Lasers (Laser)
03/2000